Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
PxaF0UqHGtpA2Mha
Listen
